These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28252)

  • 1. Importance of dopaminergic pathways and other neural systems to behavior and action of psychotropic drugs.
    Breese GR; Mueller RA; Hollister A; Mailman R
    Fed Proc; 1978 Aug; 37(10):2429-33. PubMed ID: 28252
    [No Abstract]   [Full Text] [Related]  

  • 2. [Analysis of the neurochemical mechanisms of the psychotropic action of tuftsin and its analogs].
    Val'dman AV; Bondarenko NA; Kamysheva VA; Kozlovskaia MM; Kalikhevich VN
    Biull Eksp Biol Med; 1982 Apr; 93(4):57-60. PubMed ID: 6123353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of monoamine neurotoxins: rotational responses to dopaminergic agonists after unilateral 6-OHDA and 5,6-DHT lesions of the median forebrain bundle [proceedings].
    Waddington JL; Crow TJ
    Br J Pharmacol; 1977 Mar; 59(3):465P-466P. PubMed ID: 300261
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroleptic drugs and their action on different neuronal pathways.
    Ungerstedt U; Herrera-Marschitz M; Forster C
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):34-7. PubMed ID: 2858478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Relationship of catecholamine neural systems to the behavioral alterations produced by 6-hydroxy-dopamine administration into brain.
    Cooper BR; Breese GR
    Psychopharmacol Bull; 1974 Jul; 10(3):39. PubMed ID: 4419434
    [No Abstract]   [Full Text] [Related]  

  • 6. Dopaminergic mediation of long-term behavioral effects of in utero drug exposure.
    Middaugh LD; Zemp JW
    Neurobehav Toxicol Teratol; 1985; 7(6):685-9. PubMed ID: 3835467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis.
    Fuxe K; Fredholm BB; Ogren SO; Agnati LF; Hökfelt T; Gustafsson JA
    Fed Proc; 1978 Jun; 37(8):2181-91. PubMed ID: 350633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal ganglia dopamine depletion does not alter D1 dopamine receptor binding properties.
    Trugman JM; Pronsky CJ; Wooten GF
    Adv Neurol; 1990; 53():107-10. PubMed ID: 2146858
    [No Abstract]   [Full Text] [Related]  

  • 9. [The significance of evaluating animal behavior with psychotropic drugs and especially with antidepressive agents].
    Puech A
    Encephale; 1994 Jun; 20 Spec No 2():247-9. PubMed ID: 7916286
    [No Abstract]   [Full Text] [Related]  

  • 10. Interactions between serotonergic and catecholaminergic systems in the brain.
    Kostowski W
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):15-24. PubMed ID: 1107968
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychotropic activity of the natural peptide tuftsin.
    Valdman AV
    Ann Ist Super Sanita; 1982; 18(1):9-12. PubMed ID: 6897809
    [No Abstract]   [Full Text] [Related]  

  • 12. Behavioral and neurochemical changes produced in rats by developmental treatments with psychotropic drugs.
    Cagiano R; De Salvia MA; Giustino A; Siro Brigiani G; Cuomo V
    Ann Ist Super Sanita; 1993; 29(1):175-7. PubMed ID: 8129265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Functional morphology of mediator systems of the brain].
    Otellin VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(1):54-8. PubMed ID: 9505409
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurotransmitter interactions related to central dopamine neurons.
    Lloyd KG
    Essays Neurochem Neuropharmacol; 1978; 3():129-207. PubMed ID: 30628
    [No Abstract]   [Full Text] [Related]  

  • 15. Alteration of prolactin secretion by centrally acting drugs.
    Besser GM; Yeo T; Delitala G; Grossman AB
    Adv Biochem Psychopharmacol; 1980; 24():399-406. PubMed ID: 6105790
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of catecholamines and acetylcholine in the regulation of animal behaviour.
    Herman ZS
    Acta Physiol Pol; 1980; 31 Suppl 20():57-68. PubMed ID: 7190761
    [No Abstract]   [Full Text] [Related]  

  • 17. Gamma-type endorphins and brain dopaminergic systems.
    van Ree JM; Elands J; Kiraly I; Wolterink G
    Prog Clin Biol Res; 1990; 328():287-90. PubMed ID: 1968266
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonstriatal dopaminergic neurons: Section VI. Action of dopamine at synaptic level:influence on postsynaptic cells: Introduction: action of dopamine at synaptic level: influence on postsynaptic cells.
    Iversen LL
    Adv Biochem Psychopharmacol; 1977; 16():381-3. PubMed ID: 883549
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
    Cooper BR; Breese GR
    Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of nootropic drugs on dopaminergic systems in the CNS.
    Westermann KH; Schmidt J; Bucher U
    Pol J Pharmacol Pharm; 1981 Nov; 33(4):431-6. PubMed ID: 6799944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.